Breast cancer and climacteric complaints: Weighing up risks of hormone therapy against quality of life
| Autor: | Peter Kenemans, Curt W. Burger, Marius J. van der Mooren, H.R. Franke, Monique M.A. Brood-van Zanten |
|---|---|
| Přispěvatelé: | Obstetrics & Gynecology |
| Rok vydání: | 2007 |
| Předmět: |
medicine.medical_specialty
Pediatrics medicine.medical_treatment Breast Neoplasms Breast cancer Estrogen Receptor Modulators SDG 3 - Good Health and Well-being Quality of life Risk Factors Epidemiology medicine Humans Risk factor Netherlands Gynecology business.industry Estrogen Replacement Therapy Obstetrics and Gynecology medicine.disease Menopause Increased risk Reproductive Medicine Practice Guidelines as Topic Quality of Life Female Hormone therapy Climacteric business |
| Zdroj: | European Journal of Obstetrics, Gynecology and Reproductive Biology, 134(2), 143-146. Elsevier Ireland Ltd Franke, H R, Brood-van Zanten, M M A, Burger, C W, van der Mooren, M J & Kenemans, P 2007, ' Breast cancer and climacteric complaints : Weighing up risks of hormone therapy against quality of life ', European Journal of Obstetrics and Gynecology and Reproductive Biology, vol. 134, no. 2, pp. 143-146 . https://doi.org/10.1016/j.ejogrb.2007.05.002 |
| ISSN: | 0301-2115 |
| Popis: | Women with severe menopausal symptoms can, at their request, be treated effectively with hormone therapy. Good information about the advantages and disadvantages of hormone therapy should precede this decision. For women with breast cancer or an inherited increased risk of breast cancer and severe, often therapy-related climacteric symptoms, a high degree of reticence is appropriate in relation to hormone therapy. If the quality of life is seriously affected in these often-young women with these iatrogenic climacteric complaints, then careful consideration must be given to the various treatment modalities. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect